Gerstein DR, Johnson RA, Harwood HJ, Fountain D, Suter N, Malloy K. 1994. Evaluating Recovery Services: The California Drug and Alcohol Treatment Assessment (CALDATA). Fairfax, VA: Lewin-VHI and National Opinion Research Center at the University of Chicago.

Gerstein DR, Johnson RA, Larison CL. 1997. Alcohol and Other Drug Treatment for Parents and Welfare Recipients: Outcomes, Costs, and Benefits. Washington, DC: U.S. Department of Health and Human Services.

Gostin L. 1991. An alternative public health vision for a national drug strategy: “Treatment works.” Houston Law Review. 28(1):285–308.

Gray J. 1995. Operating needle exchange programmes in the hills of Thailand. AIDS Care. 7(4):489–499.

Gray J. 1998. Harm reduction in the hills of northern Thailand. Substance Use and Misuse. 33(5):1075–1091.

Hartz D, Meek P, Piotrowski N, Tusel D, Henke C, Delucchi, Sees K, Hall S. 1999. A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment. American Journal of Drug and Alcohol Abuse. 25(2):207–218.

IOM (Institute of Medicine). 1995. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press.

IOM. 2005. Scaling Up Treatment for the Global AIDS Pandemic: Challenges and Opportunities. Washington, DC: The National Academies Press.

Laufer FN. 2001. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes. 28(3):273–278.

Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD. 2006. Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups. Clinical Infectious Diseases. 42:1628–1635.

NRC (National Research Council) and IOM (Institute of Medicine). 1995. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC: National Academy Press.

Pollack H, Heimer R. 2004. Impact and cost-effectiveness of methadone maintenance programs for HIV and hepatitis C prevention. In: Jager J, Limburg W, Kretzschmar M, Postma M, Wiessing L, eds. Hepatitis C And Injecting Drug Use: Impact, Costs, and Policy Options. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction. 7:345–371.

Quan VM, Chung A, Abdul-Quader AS. 1998. The feasibility of a syringe-needle exchange program in Vietnam. Substance Use and Misuse. 33(5):1055–1067.

Ritson EB. 1999. Alcohol, drugs and stigma. International Journal of Clinical Practice. 53:549–551.

State Welfare Organization. 2000. Drug abuse prevention in youth needs a national movement. Tehran, Iran: State Welfare Organization (unofficial translation).

Taussig J, Junge B, Burris S, Jones TS, Sterk CE. 2002. Individual and structural influences shaping pharmacists’ decisions to sell syringes to injection drug users in Atlanta, Georgia. Journal of the American Pharmaceutical Association. 42(6)Suppl 2:S40–S45.

WHO (World Health Organization), United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS. 2004. Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS Prevention: Position Paper. Geneva, Switzerland: WHO.

UNAIDS (Joint United Nations Programme on HIV/AIDS). 2006. 2006 Report on the Global AIDS Epidemic: A UNAIDS 10th Anniversary Special Edition. Geneva, Switzerland: UNAIDS.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement